Cargando…
DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update
Lung cancer is the number one cancer killer in the United States. This disease is clinically divided into two sub-types, small cell lung cancer, (10–15% of lung cancer cases), and non-small cell lung cancer (NSCLC; 85–90% of cases). Early detection of NSCLC, which is the more common and less aggress...
Autores principales: | Anglim, Paul P, Alonzo, Todd A, Laird-Offringa, Ite A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2585582/ https://www.ncbi.nlm.nih.gov/pubmed/18947422 http://dx.doi.org/10.1186/1476-4598-7-81 |
Ejemplares similares
-
Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy
por: Kazarian, Meleeneh, et al.
Publicado: (2011) -
Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancer
por: Anglim, Paul P, et al.
Publicado: (2008) -
The Role of DNA Methylation in the Development and Progression of Lung Adenocarcinoma
por: Kerr, Keith M., et al.
Publicado: (2007) -
The role of the C-terminal helix of U1A protein in the interaction with U1hpII RNA
por: Law, Michael J., et al.
Publicado: (2013) -
Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma
por: Tsou, Jeffrey A, et al.
Publicado: (2007)